- United States
- /
- Chemicals
- /
- NYSE:DD
DuPont de Nemours (NYSE:DD): Assessing Valuation After Breakthroughs in Tyvek APX and Ballistic Armor Innovation
Reviewed by Simply Wall St
DuPont de Nemours (NYSE:DD) is making headlines with the launch of Tyvek APX, its latest innovation in protective garment materials. The company has also rolled out advanced testing protocols for ballistic body armor, highlighting its ongoing push for safety and comfort solutions.
See our latest analysis for DuPont de Nemours.
In the midst of these product breakthroughs and a busy period of executive changes, DuPont de Nemours saw its share price tumble more than 50% over the past month, reflecting a sharp shift in investor sentiment. However, its total shareholder return tells a very different story, with an increase of 7.6% over the past year and a strong 45% gain over three years. While recent momentum has clearly faded, the company's history of innovation and long-term returns suggests there are still compelling reasons investors are watching closely.
If you're interested in expanding your search for standout performers, now is a great time to discover fast growing stocks with high insider ownership.
But after such a steep decline in the stock price, is DuPont de Nemours trading at a discount that investors can seize, or is the market already factoring in the next wave of innovation and growth?
Most Popular Narrative: 59.7% Undervalued
Compared to its last close price of $37.76, the most widely followed narrative estimates DuPont de Nemours’ fair value at $93.69 per share, highlighting a massive upside. The stage is set by bold assumptions about the company’s evolution and performance.
“DuPont’s accelerated growth in Electronics, particularly from AI-driven applications, advanced packaging, and high-performance computing, positions the company to capture outsized revenue expansion as node migrations and broader electronics market recovery unfold through 2025 and beyond.
Persistent strength and strategic investment in Healthcare & Water, driven by surging global demand for clean water solutions and healthcare products, leverages favorable demographic, sustainability, and infrastructure trends to drive above-peer organic revenue growth and margin stability.”
What is propelling this sky-high valuation? The narrative relies on forecasts of rapid growth in core segments, margin transformation, and aggressive future earnings targets. Can the numbers behind this conviction withstand scrutiny? Unlock the full story to see which ambitious financial pivots underpin this price target.
Result: Fair Value of $93.69 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, persistent legal liabilities and exposure to volatile global markets could undermine DuPont de Nemours’s growth prospects and create uncertainty regarding its valuation narrative.
Find out about the key risks to this DuPont de Nemours narrative.
Another View: Discounted Cash Flow Says Overvalued
Taking a different approach, our DCF model values DuPont de Nemours at just $32.62 per share. This is below the current price of $37.76, which suggests the market might be pricing in more optimism than the company's expected future cash flows support. Does this mean investors should be more cautious?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out DuPont de Nemours for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 840 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Build Your Own DuPont de Nemours Narrative
If you want to look beyond the headlines and shape your own outlook, you can dig into the data and craft a narrative faster than you might think. Do it your way.
A great starting point for your DuPont de Nemours research is our analysis highlighting 1 key reward and 5 important warning signs that could impact your investment decision.
Looking for More Investment Ideas?
Give yourself an edge in any market by searching beyond the obvious. Smart investors target opportunities that most overlook, and the right screeners make all the difference.
- Capture rapid price momentum and unearth tomorrow’s small-cap winners by checking out these 3605 penny stocks with strong financials making waves in the market.
- Secure reliable income streams with these 20 dividend stocks with yields > 3% offering yields above 3% for investors who prioritize steady returns.
- Catch the surge in digital financial innovation and monitor these 82 cryptocurrency and blockchain stocks that are driving the blockchain and crypto revolution.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:DD
DuPont de Nemours
Provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa.
Excellent balance sheet with moderate risk.
Similar Companies
Market Insights
Community Narratives

